Celldex Therapeutics(CLDX) - 2025 Q3 - Quarterly Results

EXHIBIT 99.1 Celldex Reports Third Quarter 2025 Financial Results and Provides Corporate Update HAMPTON, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported financial results for the third quarter ended September 30, 2025 and provided a corporate update. "This quarter, Celldex continued to demonstrate our leadership in the field of mast cell biology, presenting exciting data across our pipeline programs," said Anthony Marucci, Co-founder, President and Chief Executive Officer of Cel ...